What is the role of vasopressin for the treatment of systemic inflammatory response syndrome (SIRS)?

Updated: May 07, 2018
  • Author: Lewis J Kaplan, MD, FACS, FCCM, FCCP; Chief Editor: Michael R Pinsky, MD, CM, Dr(HC), FCCP, FAPS, MCCM  more...
  • Print

Similarly, in the critically ill vasoplegic patient (ie, hypotensive despite fluid resuscitation and vasopressor therapy), the use of vasopressin (0.01-0.02 mcg/kg/h) may be beneficial in decreasing vasopressor requirements without causing more ischemia. Its effects on mortality have not been proven.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!